The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Alzheimer disease in the United States (2010–2050) estimated using the 2010 census
Open accessAbstract
OBJECTIVES: To provide updated estimates of Alzheimer disease (AD) dementia prevalence in the United States from 2010 through 2050. METHODS: Probabilities of AD dementia incidence were calculated from a longitudinal, population-based study including substantial numbers of both black and white participants. Incidence probabilities for single year of age, race, and level of education were calculated using weighted logistic regression and AD dementia diagnosis from 2,577 detailed clinical evaluations of 1,913 people obtained from stratified random samples of previously disease-free individuals in a population of 10,800. These were combined with US mortality, education, and new US Census Bureau estimates of current and future population to estimate current and future numbers of people with AD dementia in the United States. RESULTS: We estimated that in 2010, there were 4.7 million individuals aged 65 years or older with AD dementia (95% confidence interval [CI] = 4.0-5.5). Of these, 0.7 million (95% CI = 0.4-0.9) were between 65 and 74 years, 2.3 million were between 75 and 84 years (95% CI = 1.7-2.9), and 1.8 million were 85 years or older (95% CI = 1.4-2.2). The total number of people with AD dementia in 2050 is projected to be 13.8 million, with 7.0 million aged 85 years or older. CONCLUSION: The number of people in the United States with AD dementia will increase dramatically in the next 40 years unless preventive measures are developed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As the U.S. population ages, the number of people with Alzheimer’s disease and related dementias (ADRD) is rapidly increasing,1,2”
From Review of Artificial Intelligence for Clinical Use in Alzheimer's Disease and Related Dementias (2026) · cites this paper as [1]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Sex is an important factor that contributes to the clinical and biological heterogeneities in Alzheimer’s disease (AD)”
From Sex-specific DNA methylation differences in Alzheimer’s disease pathology (2021) · cites this paper as [2]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The aging of the baby-boom generation will significantly increase the number of people in the United States with Alzheimer's.70”
From 2023 Alzheimer's disease facts and figures (2023) · cites this paper as [70]
The cited source says what the claim attributes to it.
In the citing paper
“The aging of the population, including the baby‐boom generation, will significantly increase the number of people in the United States with Alzheimer's dementia.”
From 2024 Alzheimer's disease facts and figures (2024) · cites this paper as [78]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Of all AD patients in the United States, around two-thirds are women [2].”
From Sex specific molecular networks and key drivers of Alzheimer’s disease (2023) · cites this paper as [2]
Experimental — accuracy not yet measured
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Almost two-thirds of AD patients in the U.S. are women [2]”
From Sex-specific DNA methylation differences in Alzheimer’s disease pathology (2021) · cites this paper as [2]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Statistical Analysis With Missing Data
Lahiff, M., Little, R. J. A., & Rubin, D. B. (1989) · Journal of the American Statistical Association · doi:10.2307/2289883 · Cited by 17,385
Statistical Analysis with Missing Data
Little, R. J. A., & Rubin, D. B. (2002) · Wiley Series in Probability and Statistics · doi:10.1002/9781119013563 · Cited by 8,473
Alzheimer Disease in the US Population: Prevalence Estimates Using the 2000 Census
Hebert, L. E., Scherr, P. A., Bienias, J. L., Bennett, D. A., & Evans, D. A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.8.1119 · Cited by 2,168
Self-citationPrevalence of Dementia in the United States: The Aging, Demographics, and Memory Study
Plassman, B. L., Langa, K. M., Fisher, G. G., Heeringa, S. G., Weir, D. R., Ofstedal, M. B., Burke, J. R., Hurd, M. D., Potter, G. G., Rodgers, W. L., et al. (2007) · Neuroepidemiology · doi:10.1159/000109998 · Cited by 1,932
Brookmeyer, R., Gray, S. G., & Kawas, C. H. (1998) · American Journal of Public Health · doi:10.2105/ajph.88.9.1337 · Cited by 1,802
2005 American Community Survey 1-Year Estimates
(2016) · Cited by 1,241
Missed and Delayed Diagnosis of Dementia in Primary Care: Prevalence and Contributing Factors
Bradford, A., Kunik, M. E., Schulz, P., Williams, S. P., & Singh, H. (2009) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e3181a6bebc · Cited by 969
Glover, J. W. (2010) · Cited by 917
Age-specific incidence rates of Alzheimer’s disease: The Baltimore Longitudinal Study of Aging
Kawas, C., Gray, S., Brookmeyer, R., Fozard, J., & Zonderman, A. (2000) · Neurology · doi:10.1212/wnl.54.11.2072 · Cited by 472
Research works printed but not linked: 1
- Bienias JL Kott PS Evans DA. Applying the delete-a-group jacknife varience estimator to analyses of data from a complex longitudinal survey . Proceedings of the Annual Meeting of the American Statistical Association Section on Survey Research Methods. Alexandria: American Statistical Association; 2003:539–544.
Cited by
Sorted by citations
Items 501–600 of 1,012
Canine Cognitive Dysfunction (CCD) scores correlate with amyloid beta 42 levels in dog brain tissue
Urfer, S. R., Darvas, M., Czeibert, K., Sándor, S., Promislow, D., Creevy, K. E., Kubinyi, E., & Kaeberlein, M. R. (2021) · GeroScience · doi:10.1007/s11357-021-00422-1 · Cited by 63
Choi, H., Heisler, M., Norton, E. C., Langa, K. M., Cho, T., & Connell, C. M. (2021) · Health Affairs · doi:10.1377/hlthaff.2021.00280 · Cited by 57
Kunutsor, S. K., Isiozor, N. M., Voutilainen, A., & Laukkanen, J. A. (2022) · GeroScience · doi:10.1007/s11357-022-00514-6 · Cited by 61
NLRP3 inflammasome in cognitive impairment and pharmacological properties of its inhibitors
Xu, Y., Yang, Y., Chen, X., Jiang, D., Zhang, F., Guo, Y., Hu, B., Xu, G., Peng, S., Wu, L., et al. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00381-x · Cited by 65
“Alzheimer’s disease (AD) is a common cause of dementia [11], primarily affecting people over the age of 60 [12].”
BackgroundRohn, T. T. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140714908 · Cited by 58
Rare Functional Variant in TM2D3 is Associated with Late-Onset Alzheimer's Disease
Jakobsdóttir, J., van der Lee, S. J., Bis, J. C., Chouraki, V. A., Li‐Kroeger, D., Yamamoto, S., Grove, M. L., Naj, A. C., Vronskaya, M., Salazar, J. L., et al. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1006327 · Cited by 58
Aguayo, S. D., Schuh, C. M. A. P., Vicente, B., & Aguayo, L. G. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180319 · Cited by 62
Mechanisms of neurodegeneration — Insights from familial Alzheimer’s disease
Chávez‐Gutiérrez, L., & Szaruga, M. (2020) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2020.03.005 · Cited by 59
Phelan, E. A., Debnam, K. J., Anderson, L. A., & Owens, S. B. (2015) · Medical Care · doi:10.1097/mlr.0000000000000294 · Cited by 55
Rorbach-Dolata, A., & Piwowar, A. (2019) · BioMed Research International · doi:10.1155/2019/1435276 · Cited by 58
Alzheimer's Patient Familial Caregivers: A Review of Burden and Interventions
Wennberg, A. M. V., Dye, C. J., Streetman-Loy, B., & Pham, H. (2015) · Health & Social Work · doi:10.1093/hsw/hlv062 · Cited by 57
Sex-specific risk of cardiovascular disease and cognitive decline: pregnancy and menopause
Miller, V. M., Garovic, V. D., Kantarci, K., Barnes, J. N., Jayachandran, M., Mielke, M. M., Joyner, M. J., Shuster, L. T., & Rocca, W. A. (2013) · Biology of Sex Differences · doi:10.1186/2042-6410-4-6 · Cited by 57
Care Received by Elderly US Stroke Survivors May Be Underestimated
Skolarus, L. E., Freedman, V. A., Feng, C., Wing, J. J., & Burke, J. F. (2016) · Stroke · doi:10.1161/strokeaha.116.012704 · Cited by 57
Mellott, T. J., Huleatt, O. M., Shade, B. N., Pender, S. M., Liu, Y. B., Slack, B. E., & Blusztajn, J. K. (2017) · PLoS ONE · doi:10.1371/journal.pone.0170450 · Cited by 54
Pardo, M., Cheng, Y., Sitbon, Y. H., Lowell, J. A., Grieco, S. F., Worthen, R. J., Desse, S. I., & Barreda-Diaz, A. (2018) · Neuroscience Research · doi:10.1016/j.neures.2018.10.012 · Cited by 61
Supervised dictionary learning of EEG signals for mild cognitive impairment diagnosis
Kashefpoor, M., Rabbani, H., & Barekatain, M. (2019) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2019.101559 · Cited by 57
Artificial Intelligence for Optimization and Interpretation of PET/CT and PET/MR Images
Zaharchuk, G., & Davidzon, G. (2020) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2020.10.001 · Cited by 61
Belonwu, S., Li, Y., Bunis, D. G., Rao, A. A., Solsberg, C. W., Tang, A., Fragiadakis, G. K., Dubal, D. B., Oskotsky, T., & Sirota, M. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02591-8 · Cited by 55
Antioxidant, anti‐inflammatory and epigenetic potential of curcumin in Alzheimer's disease
Abdul‐Rahman, T., Awuah, W. A., Mikhailova, T., Kalmanovich, J. B., Mehta, A., Ng, J. C., Coghlan, M. A., Zivcevska, M., Tedeschi, A. J., Oliveira, E. C., et al. (2024) · BioFactors · doi:10.1002/biof.2039 · Cited by 66
Investigation of Sex Differences in the Microglial Response to Binge Ethanol and Exercise
Barton, E. A., Baker, C., & Leasure, J. L. (2017) · Brain Sciences · doi:10.3390/brainsci7100139 · Cited by 55
Sex Differences in Cardiovascular Risk Factors for Dementia
Kim, M., Kim, K., Hong, C. H., Lee, S. Y., & Jung, Y.-S. (2018) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2018.159 · Cited by 60
Microorganisms’ Footprint in Neurodegenerative Diseases
Dehhaghi, M., Panahi, H. K. S., & Guillemin, G. J. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00466 · Cited by 56
Driscoll, I., Shumaker, S. A., Snively, B. M., Margolis, K. L., Manson, J. E., Vitolins, M. Z., Rossom, R. C., & Espeland, M. A. (2016) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glw078 · Cited by 55
Napping characteristics and cognitive performance in older adults
Owusu, J. T., Wennberg, A. M. V., Holingue, C., Tzuang, M., Abeson, K., & Spira, A. P. (2018) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4991 · Cited by 56
Huang, Y., Driedonks, T. A. P., Cheng, L., Turchinovich, A., Rajapaksha, H., Arab, T., Powell, B. H., Pletniková, O., Redding‐Ochoa, J., Troncoso, J. C., et al. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220322 · Cited by 58
Trajectories of Neuropsychiatric Symptoms and Cognitive Decline in Mild Cognitive Impairment
David, N. D., Lin, F. V., & Porsteinsson, A. P. (2015) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2015.06.001 · Cited by 60
A rare missense variant of CASP7 is associated with familial late‐onset Alzheimer's disease
Zhang, X., Zhu, C., Beecham, G. W., Vardarajan, B. N., Ma, Y., Lancour, D., Farrell, J. J., Chung, J., Alzheimer's Disease Sequencing Project, Mayeux, R. P., et al. (2018) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2018.10.005 · Cited by 50
Relationships between retinal layer thickness and brain volumes in the UK Biobank cohort
Chua, S. Y. L., Lascaratos, G., Atan, D., Zhang, B., Reisman, C. A., Khaw, P. T., Smith, S. M., Matthews, P. M., Petzold, A., Strouthidis, N. G., et al. (2020) · European Journal of Neurology · doi:10.1111/ene.14706 · Cited by 56
“Prevalence of dementia increases with age, affecting 11%, 32% and 82% of people aged over 65, 75 and 85 years, respectively [3].”
BackgroundPaulsen, A. J., Schubert, C. R., Pinto, A. A., Carlsson, C. M., Chappell, R. J., Fischer, M., Klein, R., Klein, R., Tsai, M. Y., & Cruickshanks, K. J. (2019) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000341 · Cited by 54
Impact of increased APP gene dose in Down syndrome and the Dp16 mouse model
Sawa, M., Overk, C., Becker, A., Derse, D., Albay, R., Weldy, K., Salehi, A., Beach, T. G., Doran, E., Head, E., et al. (2022) · Alzheimer's & Dementia · doi:10.1002/alz.12463 · Cited by 54
Optimal Emergency Department Care Practices for Persons Living With Dementia: A Scoping Review
Dresden, S. M., Taylor, Z., Serina, P. T., Kennedy, M., Wescott, A., Hogan, T. M., Shah, M. N., Hwang, U., Aggarawal, N. T., Allore, H. G., et al. (2022) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2022.05.024 · Cited by 60
“reduction, space for family members Themes around (1) impact of changes to”
InfluentialAmyloid-lowering immunotherapies for Alzheimer disease: current status and future directions
Rafii, M. S., & Aisen, P. S. S. (2025) · Nature Reviews Neurology · doi:10.1038/s41582-025-01123-5 · Cited by 62
“Whereas only 3% of individuals aged 65 to 74 years are affected, the rate climbs to 17% among those aged 75 to 84 years and reaches 32% in individuals aged 85 years and older 3 .”
Ashby, E. L., & Kehoe, P. G. (2013) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2013.812631 · Cited by 55
Mayeda, E. R. (2019) · American Journal of Epidemiology · doi:10.1093/aje/kwz047 · Cited by 52
Estrogen activates Alzheimer's disease genes
Ratnakumar, A., Zimmerman, S. E., Jordan, B. A., & Mar, J. C. (2019) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1016/j.trci.2019.09.004 · Cited by 52
Age-Related Changes in Spatial Navigation Are Evident by Midlife and Differ by Sex
Yu, S., Boone, A. P., He, C., Davis, R. C., Hegarty, M., Chrastil, E. R., & Jacobs, E. G. (2021) · Psychological Science · doi:10.1177/0956797620979185 · Cited by 56
The Molecular Effects of Environmental Enrichment on Alzheimer’s Disease
Liew, A. K. Y., Teo, C. H., & Soga, T. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-03016-w · Cited by 61
“An estimated 3% of adults aged 65–74, 17% of adults aged 75–84 and 32% adults aged 85 or older suffer from the disease [6].”
BackgroundSingh, S., Orešković, T., Carr, S., Papier, K., Conroy, M. C., Senff, J. R., Chemali, Z. N., Gutiérrez-Martínez, L., Parodi, L., Mayerhofer, E., et al. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1291020 · Cited by 57
Yang, T., Wang, J., Sun, Q., Hibar, D. P., Jahanshad, N., Liu, L., Wang, Y., Zhan, L., Thompson, P. M., & Ye, J. (2015) · IEEE International Symposium on Biomedical Imaging (ISBI) · doi:10.1109/isbi.2015.7164036 · Cited by 53
Inflammatory Mediators as Biomarkers in Brain Disorders
Nuzzo, D., Picone, P., Caruana, L., Vasto, S., Barera, A., Caruso, C., & Carlo, M. D. (2013) · Inflammation · doi:10.1007/s10753-013-9780-2 · Cited by 56
Chernick, D., Ortiz‐Valle, S., Jeong, A., Swaminathan, S. K., Kandimalla, K. K., Rebeck, G. W., & Li, L. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14554 · Cited by 51
Hsp90 co-chaperones, FKBP52 and Aha1, promote tau pathogenesis in aged wild-type mice
Criado‐Marrero, M., Gebru, N. T., Blazier, D. M., Gould, L. A., Baker, J. D., Beaulieu‐Abdelahad, D., & Blair, L. J. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01159-w · Cited by 53
Beydoun, M. A., Beydoun, H. A., Gamaldo, A. A., Rostant, O. S., Dore, G. A., Zonderman, A. B., & Eid, S. M. (2015) · Journal of Alzheimer's Disease · doi:10.3233/jad-150228 · Cited by 52
Leung, Y. Y., Valladares, O., Chou, Y., Lin, H., Kuzma, A. B., Cantwell, L. B., Qu, L., Gangadharan, P., Alzheimer's Disease Sequencing Project, Salerno, W. J., et al. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty894 · Cited by 52
Li, W., Li, S., Shang, Y., Zhuang, W., Yan, G., Chen, Z., & Lyu, J. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1117056 · Cited by 52
A systematic review and methodological analysis of EEG-based biomarkers of Alzheimer's disease
Modir, A., Shamekhi, S., & Ghaderyan, P. (2023) · Measurement · doi:10.1016/j.measurement.2023.113274 · Cited by 52
Friedman, D. B., Becofsky, K. M., Anderson, L. A., Bryant, L. L., Hunter, R., Ivey, S. L., Belza, B. L., Logsdon, R. G., Brannon, S., Vandenberg, A. E., et al. (2015) · International Psychogeriatrics · doi:10.1017/s1041610214002877 · Cited by 52
Porter, C. N., Miller, M. C., Lane, M. J., Cornman, C. B., Sarsour, K., & Kahle‐Wrobleski, K. (2016) · SAGE Open Medicine · doi:10.1177/2050312116661877 · Cited by 51
Pierce, A. L., Bullain, S., & Kawas, C. H. (2017) · Neurologic Clinics · doi:10.1016/j.ncl.2017.01.006 · Cited by 54
Hearing loss is an early biomarker in APP/PS1 Alzheimer’s disease mice
Liu, Y., Fang, S., Liu, L.-M., Zhu, Y., Li, C.-R., Chen, K., & Zhao, H. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.134705 · Cited by 51
Prevalence of dementia in India: A systematic review and meta-analysis
Ranjan, J. K., Choudhary, A., & Asthana, H. S. (2021) · Indian Journal of Public Health · doi:10.4103/ijph.ijph_1042_20 · Cited by 53
Ashford, M. T., Raman, R., Miller, G., Donohue, M. C., Okonkwo, O. C., Mindt, M. R., Nosheny, R. L., Coker, G. A., Petersen, R. C., Aisen, P. S., et al. (2022) · Alzheimer's & Dementia · doi:10.1002/alz.12640 · Cited by 51
The Impact of Neurotransmitters on the Neurobiology of Neurodegenerative Diseases
Davis, S. E., Cirincione, A. B., Jiménez-Torres, A. C., & Zhu, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242015340 · Cited by 55
“Considering the progressive nature of neurodegenerative diseases, it is probably unsurprising that aging is a risk factor for NDs, and as populations live longer, NDs are becoming more prevalent [169].”
BackgroundProjecting Burden of Dementia in Spain, 2010–2050: Impact of Modifying Risk Factors
Soto‐Gordoa, M., Arrospide, A., Moreno, F., Martínez‐Lage, P., Castilla‐Rodríguez, I., & Mar, J. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150233 · Cited by 50
Macera, C. A., Cavanaugh, A. M., & Bellettiere, J. (2015) · American Journal of Lifestyle Medicine · doi:10.1177/1559827615571897 · Cited by 58
Epigenetic assimilation in the aging human brain
Oh, G., Ebrahimi, S. B., Wang, S.-C., Cortese, R., Kaminsky, Z. A., Gottesman, I. I., Burke, J. R., Plassman, B. L., & Petronis, A. (2016) · Genome biology · doi:10.1186/s13059-016-0946-8 · Cited by 54
Yacoubian, T. A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802810-0.00001-5 · Cited by 56
Behzadfar, L., Abdollahi, M. R., Sabzevari, O., Hosseini, R., Salimi, A., Naserzadeh, P., Sharifzadeh, M. S., & Pourahmad, J. (2017) · Metallomics · doi:10.1039/c7mt00075h · Cited by 52
Coexistence of Multiple Sclerosis and Alzheimer's disease: A review
Luczynski, P., Laule, C., Hsiung, G. R., Moore, G. R. W., & Tremlett, H. L. (2018) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2018.10.109 · Cited by 52
Kodidela, S., Gerth, K. A., Haque, S., Gong, Y., Ismael, S., Singh, A. K., Ishrat, T., & Kumar, S. (2019) · Cells · doi:10.3390/cells8090968 · Cited by 51
Törnquist, M., Cukalevski, R., Weininger, U., Meisl, G., Knowles, T. P. J., Leiding, T., Malmendal, A., Akke, M., & Linse, S. S. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1918481117 · Cited by 51
Is sleep disruption a risk factor for Alzheimer's disease?
Macedo, A. C., Balouch, S., & Tabet, N. (2017) · Journal of Alzheimer’s Disease · doi:10.3233/jad-161287 · Cited by 49
Ostrand, R., & Gunstad, J. (2021) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988720933358 · Cited by 49
Prospects for strain-specific immunotherapy in Alzheimer’s disease and tauopathies
Bittar, A., Sengupta, U., & Kayed, R. (2018) · npj Vaccines · doi:10.1038/s41541-018-0046-8 · Cited by 50
Eavri, R., Shepherd, J. D., Welsh, C. A., Flanders, G. H., Bear, M. F., & Nedivi, E. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.0808-18.2018 · Cited by 49
Recent advances in structural tailoring of BiOX-based 2D composites for solar energy harvesting
Raza, A., Qin, Z., Ahmad, S. O. A., Ikram, M., & Li, G. (2021) · Journal of environmental chemical engineering · doi:10.1016/j.jece.2021.106569 · Cited by 50
Ye, X., Wang, H., Cheng, S.-Q., Xia, L., Xu, X.-F., & Li, X.-R. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.890046 · Cited by 50
“It is estimated that the number of patients may increase double in the coming decades due to the lack of effective prevention and proper treatment (Hebert et al., 2013; Scheltens et al., 2021).”
BackgroundTowards universal therapeutics for memory disorders
Sun, M., Nelson, T. J., & Alkon, D. L. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.04.004 · Cited by 51
Alzheimer Disease: Perspectives from Epidemiology and Genetics
Haines, J. L. (2018) · The Journal of Law Medicine & Ethics · doi:10.1177/1073110518804230 · Cited by 51
Kennedy, M., Koehl, J. L., Shenvi, C., Greenberg, A., Zurek, O., LaMantia, M. A., & Lo, A. X. (2020) · Journal of the American College of Emergency Physicians Open · doi:10.1002/emp2.12110 · Cited by 53
Gaitán, J. M., Boots, E. A., Dougherty, R. J., Oh, J. M., Ma, Y., Edwards, D. F., Christian, B. T., Cook, D. B., & Okonkwo, O. C. (2019) · Brain Plasticity · doi:10.3233/bpl-190093 · Cited by 49
Sex specific molecular networks and key drivers of Alzheimer’s disease
Guo, L., Cao, J., Hou, J., Li, Y., Huang, M., Zhu, L., Zhang, L., Lee, Y., Duarte, M. L., Zhou, X., et al. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00624-5 · Cited by 49
Dougherty, R. J., Jonaitis, E. M., Gaitán, J. M., Lose, S. R., Mergen, B. M., Johnson, S. C., Okonkwo, O. C., & Cook, D. B. (2021) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12212 · Cited by 52
Renke, M. B., Marcinkowska, A. B., Kujach, S., & Winklewski, P. J. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.803332 · Cited by 50
“…be explained due to the fact that the increased prevalence of cerebrovascular and neurodegenerative disorders correlates with age, which is one the greatest risk factors of late-onset Alzheimer’s disease (AD) and other types of dementia (Hebert et al., 2010, 2013; Alzheimer’s Association, 2019).”
BackgroundInfluentialXu, Z., Elrashidy, R. A., Li, B., & Liu, G. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.812967 · Cited by 53
What does heritability of Alzheimer’s disease represent?
Baker, E. A., Leonenko, G., Schmidt, K. M., Hill, M., Myers, A., Shoai, M., de Rojas, I., Tesi, N., Holstege, H. H., van der Flier, W. M., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0281440 · Cited by 55
“The disease prevalence at this age is reported as something between 17–32% [26].”
BackgroundAyaz, M., Mosa, O. F., Nawaz, A., Hamdoon, A. A. E., Elkhalifa, M. E. M., Sadiq, A., Ullah, F., Ahmed, A., Kabra, A., Khan, H. Z., et al. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.155272 · Cited by 53
Driving Errors in Persons with Dementia
Barco, P. P., Baum, C. M., Ott, B. R., Ice, S., Johnson, A., Wallendorf, M., & Carr, D. B. (2015) · Journal of the American Geriatrics Society · doi:10.1111/jgs.13508 · Cited by 49
Alzheimer’s Disease, Anesthesia, and Surgery: A Clinically Focused Review
Berger, M., Burke, J. R., Eckenhoff, R. G., & Mathew, J. P. (2014) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2014.04.014 · Cited by 49
Cannabinoids in late‐onset Alzheimer's disease
Ahmed, A., van der Marck, M. A., van den Elsen, G., & Rikkert, M. O. (2015) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.117 · Cited by 50
Martínez-Pérez, B., Díez, I. D. L. T., López-Coronado, M., & de Abajo, B. S. (2014) · JMIR mhealth and uhealth · doi:10.2196/mhealth.2779 · Cited by 49
Shi, Y., Pan, T., & Liao, V. H. (2016) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.6b02779 · Cited by 49
Upward drift in cerebrospinal fluid amyloid β 42 assay values for more than 10 years
Schindler, S. E., Sutphen, C. L., Teunissen, C. E., McCue, L. M., Morris, J. C., Holtzman, D. M., Mulder, S. D., Scheltens, P., Xiong, C., & Fagan, A. M. (2017) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2017.06.2264 · Cited by 48
Trompetero, A., Gordillo, A., del Pilar, M. C., Cristina, V., & Bustos, R. (2017) · Current Pharmaceutical Design · doi:10.2174/1381612823666170828133059 · Cited by 49
Schmeltz, M. T., & Gamble, J. L. (2017) · PLoS ONE · doi:10.1371/journal.pone.0186509 · Cited by 54
Associations between quantitative sleep EEG and subsequent cognitive decline in older women
Djonlagic, I. E., Aeschbach, D., Harrison, S. L., Dean, D., Yaffe, K. S., Ancoli‐Israel, S., Stone, K. L., & Redline, S. S. (2018) · Journal of Sleep Research · doi:10.1111/jsr.12666 · Cited by 51
Vatner, D. E., Zhang, J., Oydanich, M. K., Guers, J. J., Katsyuba, E., Yan, L., Sinclair, D. A., Auwerx, J. H., & Vatner, S. F. (2018) · Aging Cell · doi:10.1111/acel.12751 · Cited by 48
Cachexia and advanced dementia
Minaglia, C., Giannotti, C., Boccardi, V., Mecocci, P., Serafini, G., Odetti, P. R., & Monacelli, F. (2019) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12380 · Cited by 56
Neuroimmunology of the female brain across the lifespan: Plasticity to psychopathology
Barrientos, R. M., Brunton, P. J., Lenz, K. M., Pyter, L. M., & Spencer, S. J. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.03.010 · Cited by 50
Paranjpe, M. D., Belonwu, S., Wang, J. K., Oskotsky, T., Gupta, A., Taubes, A., Zalocusky, K. A., Paranjpe, I., Glicksberg, B. S., Huang, Y., et al. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.735611 · Cited by 49
Kerbage, C., Sadowsky, C., Tariot, P. N., Agronin, M., Alva, G., Turner, F. D., Nilan, D., Cameron, A., Cagle, G. D., & Hartung, P. D. (2014) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317513520214 · Cited by 49
Association of work-family experience with mid- and late-life memory decline in US women
Mayeda, E. R., Mobley, T. M., Weiss, R. E., Murchland, A. R., Berkman, L. F., & Sabbath, E. L. (2020) · Neurology · doi:10.1212/wnl.0000000000010989 · Cited by 48
Neuromodulation for restoring memory
Bick, S. K. B., & Eskandar, E. N. (2016) · Neurosurgical FOCUS · doi:10.3171/2016.3.focus162 · Cited by 48
Polychlorinated biphenyls induce oxidative stress and metabolic responses in astrocytes
McCann, M. S., Fernandez, H. R., Flowers, S. A., & Maguire‐Zeiss, K. A. (2021) · NeuroToxicology · doi:10.1016/j.neuro.2021.07.001 · Cited by 51
Nasal delivery of neurotherapeutics via nanocarriers: Facets, aspects, and prospects
Rajput, A., Pingale, P., & Dhapte-Pawar, V. S. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.979682 · Cited by 54
“In the United States, around 3% population aging between 65 and 74, 17% population aging between 75 and 84, and 32% population aging 85 and above are suffering from AD (Hebert et al., 2013; Ageing, 2021).”
BackgroundPassive Immunization in JNPL3 Transgenic Mice Using an Array of Phospho-Tau Specific Antibodies
d’Abramo, C., Acker, C. M., Jimenez, H. T., & Davies, P. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135774 · Cited by 49
Biomarkers in the Diagnosis and Prognosis of Alzheimer’s Disease
Schaffer, C., Sarad, N., DeCrumpe, A., Goswami, D., Herrmann, S., Morales, J., Patel, P., & Osborne, J. (2014) · SLAS TECHNOLOGY · doi:10.1177/2211068214559979 · Cited by 50
Marx, K., Stanley, I. H., Haitsma, K. S. V., Moody, J., Alonzi, D., Hansen, B. R., & Gitlin, L. N. (2014) · Journal of Gerontological Nursing · doi:10.3928/00989134-20140905-01 · Cited by 48
Arranz‐Gibert, P., Guixer, B., Malakoutikhah, M., Muttenthaler, M., Guzmán, F., Teixidò, M., & Giralt, E. (2015) · Journal of the American Chemical Society · doi:10.1021/jacs.5b02050 · Cited by 49
Song, M. K., Bischoff, D. S., Song, A. M., Uyemura, K., & Yamaguchi, D. T. (2016) · BBA Clinical · doi:10.1016/j.bbacli.2016.09.003 · Cited by 48
Metadata
- Authors
- Hebert, L. E., Weuve, J., Scherr, P. A., & Evans, D. A.
- Affiliations
- Rush University (US)
- Venue
- Neurology
- Published
- 2013-05-07
- Volume
- 80
- Issue
- 19
- Pages
- 1778-1783
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- PMC
- PMC3719424
- OpenAlex
- W2071068165
- Cited by
- 2,642
- References
- 19
- Citations by year
- 2026: 81 · 2025: 119 · 2024: 192 · 2023: 167 · 2022: 242 · 2021: 312 · 2020: 317 · 2019: 232 · 2018: 210 · 2017: 212 · 2016: 217 · 2015: 160 · 2014: 129 · 2013: 47
- FWCI
- 131.30
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Neurology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Alzheimer's Association
- National Institutes of Health (AG011101)
- National Institute on Aging (RC2AG036650, U01AG012505, R01AG030146, AG011101, R01AG011101, P30AG010161, R01AG021972, R01AG009966)
- National Heart, Lung, and Blood Institute (R01HL084209)
- National Institute of Nursing Research (R01NR009543, R01NR010211)
- National Institute of Environmental Health Sciences (R21ES020404, R01ES010902, R21ES019712)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Social Sciences › Demography › Insurance, Mortality, Demography, Risk Management
- Keywords
- Alzheimer's disease, dementia prevalence, population projections, older adults, age-specific prevalence, racial differences, educational attainment, population aging, United States
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Female, Forecasting, Humans, Longitudinal Studies, Male, Population Surveillance, United States, Incidence, Censuses
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
